These findings establish FOXA1 as a multidimensional regulator of NPC pathogenesis and therapeutic resistance, functioning through both autonomous transcriptional control and cooperative chromatin remodeling with transcriptional co-factors. Here, FOXA1 is linked to nasopharyngeal carcinoma.